The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin
Open accessAbstract
The flavonoid silibinin, the main compound extracted from the milk thistle Silybum marianum, displays hepatoprotective properties in acute and chronic liver injury. To further elucidate the mechanisms by which it acts, we studied the effects of silibinin on different functions of isolated rat Kupffer cells, namely the formation of superoxide anion radical (0 2 −), nitric oxide (NO), tumor necrosis factor α (TNF- α), prostaglandin E 2 (PGE 2), and leukotriene B 4 (LTB 4). Production of 0 2 − and NO were inhibited in a dose-dependent manner, with an 50% inhibitory concentration (IC 50) value around 80 μmol/L. No effect on TNF-α formation was detected. Opposite effects were found on the cyclooxygenase and 5-lipoxygenase pathway of arachidonic acid metabolism. Whereas no influence on PGE 2 formation was observed with silibinin concentrations up to 100 μmol/L, a strong inhibitory effect on LTB 4 formation became evident. The IC 50- value for inhibiting the formation of this eicosanoid was determined to be 15 μmol/L silibinin. The strong inhibition of LTB 4, formation by silibinin was confirmed in experiments with phagocytic cells isolated from human liver. Hence, while rather high concentrations of silibinin are necessary to diminish free radical formation by activated Kupffer cells, significant inhibition of the 5-lipoxy-genase pathway already occurs at silibinin concentrations which are achieved in vivo. Selective inhibition of leukotriene formation by Kupffer cells can at least partly account for the hepatoprotective properties of silibinin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90224-7 · Cited by 2,194
Prostaglandins, Arachidonic Acid, and Inflammation
Kuehl, F. A., & Egan, R. W. (1980) · Science · doi:10.1126/science.6254151 · Cited by 708
Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids
Ferrándiz, M. L., & Alcaraz, M. J. (1991) · Agents and Actions · doi:10.1007/bf01980887 · Cited by 313
Silymarin protects against paracetamol‐induced lipid peroxidation and liver damage
Muriel, P., Garciapiña, T., Perez‐Alvarez, V., & Mourelle, M. (1992) · Journal of Applied Toxicology · doi:10.1002/jat.2550120613 · Cited by 301
Flavonoids and related compounds as inhibitors of arachidonic acid peroxidation
Baumann, J., v. Bruchhausen, F., & Wurm, G. (1980) · Prostaglandins · doi:10.1016/0090-6980(80)90103-3 · Cited by 253
Flavonoids: Potent inhibitors of arachidonate 5-lipoxygenase
Yoshimoto, T., Furukawa, M., Yamamoto, S., Horie, T., & Watanabe-Kohno, S. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90568-5 · Cited by 199
Campos, R., Garrido, A., Guerra, R., & Valenzuela, A. (1989) · Planta Medica · doi:10.1055/s-2006-962055 · Cited by 180
PREVENTION OF CCL4‐INDUCED LIVER CIRRHOSIS BY SILYMARIN
MOURELLE, M., MURIEL, P., FAVARI, L., & FRANCO, T. (1989) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1989.tb00449.x · Cited by 159
Kupffer Cells: Their Activation and Role in Animal Models of Liver Injury and Human Liver Disease
Winwood, P., & Arthur, M. J. P. (1993) · Seminars in Liver Disease · doi:10.1055/s-2007-1007337 · Cited by 154
Valenzuela, A., Lagos, C., Schmidt, K., & Videla, L. A. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90421-6 · Cited by 142
IOANNIDIS, I., & de GROOT, H. (1993) · Biochemical Journal · doi:10.1042/bj2960341 · Cited by 129
Valenzuela, A., Guerra, R., & Videla, L. A. (1986) · Planta Medica · doi:10.1055/s-2007-969247 · Cited by 125
Liver cytoprotection by prostaglandins
Quiroga, J. A., & Prìeto, J. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90067-n · Cited by 120
Luminol Chemiluminescence in Rat Macrophages and Granulocytes: The Role of NO, O−2-/H2O2, and HOCl
Wang, J., Komarov, P. G., & Degroot, H. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1338 · Cited by 78
Self-citationValenzuela, A., & Guerra, R. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80278-7 · Cited by 49
Silymarin, an inhibitor of prostaglandin synthetase
Fiebrich, F., & Koch, H. (1979) · Cellular and Molecular Life Sciences · doi:10.1007/bf01953185 · Cited by 41
Cited by
Flavonoids: a review of probable mechanisms of action and potential applications
Nijveldt, R. J., van Nood, E., van Hoorn, D. E., Boelens, P. G., van Norren, K., & van Leeuwen, P. A. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.4.418 · Cited by 3,075
The molecular basis of working mechanism of natural polyphenolic antioxidants
Leopoldini, M., Russo, N., & Toscano, M. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2010.08.012 · Cited by 1,266
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
Surai, P. (2015) · Antioxidants · doi:10.3390/antiox4010204 · Cited by 738
The Use of Silymarin in the Treatment of Liver Diseases
Saller, R., Meier, R., & Brignoli, R. (2001) · Drugs · doi:10.2165/00003495-200161140-00003 · Cited by 718
Metadata
- Authors
- Dehmlow, C., Erhard, J., & de Groot, H.
- Venue
- Hepatology
- Published
- 1996-04
- Volume
- 23
- Issue
- 4
- Pages
- 749-754
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1973760627
- Cited by
- 290
- References
- 18
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.